You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

noncontiguous stage II adult Burkitt lymphoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Postoperative Nausea and Vomiting, Postoperative Nausea and Vomiting \(PONV\)Acuppressure Trial in Kuala Lumpur (Accupressure

Completed
  • Postoperative Nausea and Vomiting
  • Postoperative Nausea and Vomiting \(PONV\)Acuppressure
  • Accupressure band
  • Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
    Hospital Canselor Tuanku Muhriz
Sep 13, 2023

AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)

Not yet recruiting
  • AML, Adult
  • Amersfoort, Netherlands
  • +17 more
Aug 23, 2023

Mantle-Cell Lymphoma Trial in Worldwide (Ibrutinib, Venetoclax, Placebo Oral tablet to match Venetoclax)

Active, not recruiting
  • Mantle-Cell Lymphoma
  • Tucson, Arizona
  • +119 more
Dec 29, 2021

Solid Tumor Trial in Seoul (Gefitinib)

Completed
  • Solid Tumor
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Robotic Surgery inDedicated Multidisciplinary Pediatric Program

Recruiting
  • Surgery
    • Paris, France
      Hôpital Necker -Enfants Malades
    Dec 7, 2022

    Malnutrition Trial in Lille, Nice (Sondalis® HP 2 kcal (with or without fibre))

    Not yet recruiting
    • Malnutrition
    • Sondalis® HP 2 kcal (with or without fibre)
    • Lille, France
    • +1 more
    Jun 20, 2022

    Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema, Chronic Bronchitis Trial in United States (Prochymal™, Placebo)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • +2 more
    • Los Angeles, California
    • +5 more
    Dec 20, 2021

    Spinal Cord Injuries Trial in Cleveland (Gabapentin, Placebo)

    Recruiting
    • Spinal Cord Injuries
    • Cleveland, Ohio
      MetroHealth Medical Center
    Mar 29, 2022

    Advanced Salivary Gland Carcinoma Trial in Shanghai (SHR-A1811, SHR 3680 + leuprolide, SHR-A1921)

    Not yet recruiting
    • Advanced Salivary Gland Carcinoma
    • Shanghai, China
      Dongmei Ji
    Jun 21, 2023

    Coronary Artery Disease, Acute Liver Failure, Liver Transplant Trial in Royal Oak (CTA/FFRct, SOC cardiovascular evaluation)

    Not yet recruiting
    • Coronary Artery Disease
    • +2 more
    • CTA/FFRct
    • SOC cardiovascular evaluation
    • Royal Oak, Michigan
      William Beaumont Hospital
    Jul 21, 2022

    Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

    Recruiting
    • Non-Small-Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Guangdong General Hospital
    Apr 20, 2022

    Gut Microbiota, Hyperglycemia, Hypercholesterolemia Trial in Ciudad Guzmán (Sustainable diet promotion through behavioral change

    Not yet recruiting
    • Gut Microbiota
    • +11 more
    • Sustainable diet promotion through behavioral change intervention
    • Ciudad Guzmán, Jalisco, Mexico
      Mariana Lares Michel
    Jul 13, 2022

    Solid Tumors, Lymphoma Trial in Boston, Philadelphia (PM00104)

    Terminated
    Has Results
    • Solid Tumors
    • Lymphoma
    • Boston, Massachusetts
    • +1 more
    Jul 7, 2021

    Colorectal Cancer, Circulating Tumor DNA, Adjuvant Chemo Trial in Denmark (Capox (or FOLFOX) including flouropyrimidine and

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Capox (or FOLFOX) including flouropyrimidine and oxaliplatin combination chemotherapy
    • Intensified Follow-up Schedule
    • Aalborg, Denmark
    • +3 more
    Feb 24, 2022

    Influenza Trial in Tokyo, Osaka (QIV-HD by IM, QIV-SD by SC, QIV-HD by SC)

    Completed
    Has Results
    • Influenza
    • QIV-HD by IM
    • +2 more
    • Tokyo, Japan
    • +1 more
    Mar 24, 2022

    Plasma Cell Myeloma Trial in Jacksonville (procedure, biological, drug)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +2 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Mar 25, 2022

    Advanced/Metastatic Solid Tumors Trial in China, Italy, United States (NMS-03305293)

    Recruiting
    • Advanced/Metastatic Solid Tumors
    • Houston, Texas
    • +6 more
    Mar 14, 2022

    Epithelial Ovarian Cancer Trial (Niraparib)

    Not yet recruiting
    • Epithelial Ovarian Cancer
    • (no location specified)
    May 19, 2022

    Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

    Recruiting
    • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
    • +2 more
    • Ipilimumab
    • +3 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Feb 11, 2022

    Stroke Trial in Charlotte (Xeomin®)

    Recruiting
    • Stroke
    • Charlotte, North Carolina
      Carolinas Rehabilitation
    Apr 19, 2022

    Healthy Participants Trial in Dallas (CK-3828136, Placebo for CK-3828136)

    Recruiting
    • Healthy Participants
    • Dallas, Texas
      Labcorp Clinical Research Unit Inc.
    Dec 20, 2022

    Ischemia, Reperfusion Injury Trial in New York (Non-Physiological Feedback CPR, Physiological Feedback CPR)

    Recruiting
    • Ischemia
    • Reperfusion Injury
    • Non-Physiological Feedback CPR
    • Physiological Feedback CPR
    • New York, New York
      NYU Langone Health
    Jun 16, 2022

    GCF PLAP-1, Sclerostin and TNF-a Levels in Periodontitis

    Completed
    • Periodontitis
    • Periodontal clinical measurements and GCF sampling
    • Aydın, Turkey
      Adnan Menderes University, Faculty of Dentistry, Department of P
    Dec 8, 2022

    Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma Trial in Nashville (CTX131)

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • +4 more
    • CTX131
    • Nashville, Tennessee
      Research Site 1
    Mar 21, 2023

    Leukemia, Lymphoma, Lymphoproliferative Disorder Trial in Scottsdale, Jacksonville, Rochester (Everolimus)

    Completed
    Has Results
    • Leukemia
    • +2 more
    • Scottsdale, Arizona
    • +2 more
    Oct 11, 2019